TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15871441

Group type: EXPERIMENTAL
Intervention: Formoterol 10 microg BID via Certihaler
Number of subjects: 265

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265

Group type: COMPARATOR
Intervention: Albuterol 180 microg QID via pMDI
Number of subjects: 265
Study: 14712886

Group type: EXPERIMENTAL
Intervention: Telmisartan (40 mg uptitrated to 80 mg after four weeks, if needed)
Number of subjects: 375

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 375
Study: 10646047

Group type: EXPERIMENTAL
Intervention: Racecadotril (100 mg three times daily)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 8910097

Group type: EXPERIMENTAL
Intervention: 3‐carbon compounds pyruvate and dihydroxyacetone (PD)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (PL, polyglucose)
Number of subjects: 17
Study: 2052309

Group type: EXPERIMENTAL
Intervention: Contact lens fundus biomicroscopy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control eyes
Number of subjects: 20
Study: 6488496

Group type: EXPERIMENTAL
Intervention: Enzymatic estimates of myocardial infarct size based on plasma levels of MB creatine kinase (MB‐CK)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (anatomic infarct size measurements)
Number of subjects: 37
Study: 30891824

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 80
Study: 28013098

Group type: EXPERIMENTAL
Intervention: Prequit Nicotine Patch
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Prequit Nicotine Gum
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Preparation Counseling
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Intensive Cessation In‐Person Counseling
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Intensive Cessation Telephone Counseling
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: 16 Weeks of Combination Nicotine Replacement Therapy (NRT)
Number of subjects: 637

Group type: COMPARATOR
Intervention: 8 Weeks of Combination Nicotine Replacement Therapy (NRT)
Number of subjects: 637

Group type: COMPARATOR
Intervention: Counseling Interventions
Number of subjects: 637
Study: 27290960

Group type: EXPERIMENTAL
Intervention: 50 mg dexketoprofen trometamol
Number of subjects: 60

Group type: COMPARATOR
Intervention: 75 mg diclofenac sodium
Number of subjects: 60
Study: 24398115

Group type: EXPERIMENTAL
Intervention: Massage and stretching exercises
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Relaxation and imagination therapies
Number of subjects: 72

Group type: COMPARATOR
Intervention: Dental treatment
Number of subjects: 72
Study: 22093943

Group type: EXPERIMENTAL
Intervention: Gefitinib (GFT) 250mg/day continuously
Number of subjects: 59

Group type: COMPARATOR
Intervention: Temozolomide (TMZ) 75mg/m² for 21/28 days
Number of subjects: 59
Study: 20353109

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment in active stage group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment in resting stage group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment in recovery stage group
Number of subjects: 40
Study: 17392541

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 15798682

Group type: EXPERIMENTAL
Intervention: Ceramic veneering of fixed partial dentures (FPDs)
Number of subjects: 40

Group type: COMPARATOR
Intervention: As-cast fixed partial dentures (FPDs)
Number of subjects: 40
Study: 12090409

Group type: EXPERIMENTAL
Intervention: Intent‐to‐treat analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complier average causal effect estimation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monte Carlo simulations
Number of subjects: 0
Study: 9861507

Group type: EXPERIMENTAL
Intervention: ComputerLink intervention (Wyse 30 terminals, online services including encyclopedia, communication, decision support)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: ComputerLink intervention
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 57
Study: 7617527

Group type: EXPERIMENTAL
Intervention: Mannitol 0.755g/200ml
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Mannitol 1.509g/200ml
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Mannitol 2.264g/200ml
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (radiolabelled purified water)
Number of subjects: 8
Study: 2232833

Group type: COMPARATOR
Intervention: Standard hypothermic cardioplegic solution
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cardioplegic solution supplemented with deferoxamine 1000 mg/L
Number of subjects: 14
Study: 758132

Group type: EXPERIMENTAL
Intervention: Propylthiouracil (PTU) 300 mg daily
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Serum T3-levels
Number of subjects: 124
Study: 30522967

Group type: EXPERIMENTAL
Intervention: Regorafenib 160 mg once daily for the first 3 weeks of each 4-week cycle
Number of subjects: 119

Group type: COMPARATOR
Intervention: Lomustine 110 mg/m2 once every 6 weeks
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 119

Group type: COMPARATOR
Intervention: Lomustine
Number of subjects: 119
Study: 29133648

Group type: EXPERIMENTAL
Intervention: Modified hang-back lateral rectus recession with adjustable knot
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional hang-back recession with adjustable knot
Number of subjects: 0
Study: 25193976

Group type: EXPERIMENTAL
Intervention: Cognitive Adaptation Training (CAT)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy for psychosis (CBTp)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Multi-modal Cognitive treatment (combination of CBTp and CAT)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Treatment as Usual
Number of subjects: 166
Study: 23593645

Group type: EXPERIMENTAL
Intervention: G77-n (oven drying at 77°C, non-aging)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: G77-a (oven drying at 77°C, aging)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: GHF-n (etching with hydrofluoric acid 10% + rinsing with water at room temperature, non-aging)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: GHF-a (etching with hydrofluoric acid 10% + rinsing with water at room temperature, aging)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: G20-n (silanization, non-aging)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: G20-a (silanization, aging)
Number of subjects: 50
Study: 21781528

Group type: EXPERIMENTAL
Intervention: Taxol and cisplatin combined chemotherapy (TP)
Number of subjects: 87
Study: 20205024

Group type: EXPERIMENTAL
Intervention: Genetic/biological attributions of obesity
Number of subjects: 421
Study: 17126116

Group type: EXPERIMENTAL
Intervention: Bicaval orthotopic heart transplantation with DeVega tricuspid valve annuloplasty (TVA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard bicaval orthotopic heart transplantation (STD)
Number of subjects: 60
Study: 15266195

Group type: EXPERIMENTAL
Intervention: LISA-T prevention program (cognitive-behavioral therapy concepts, 10 meetings of 1.5 hours)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Nontreatment control group
Number of subjects: 324
Study: 11438417

Group type: EXPERIMENTAL
Intervention: Fludarabine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ChOP
Number of subjects: 0

Group type: COMPARATOR
Intervention: CAP
Number of subjects: 0
Study: 9150331

Group type: EXPERIMENTAL
Intervention: Home intravenous (i.v.) antibiotic therapy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Hospital therapy
Number of subjects: 17
Study: 8429112

Group type: EXPERIMENTAL
Intervention: Zofenopril calcium (7.5 mg, 15 mg, 30 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3113280

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG) 10 mg four times daily
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ketotifen 1 mg twice daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29898700

Group type: EXPERIMENTAL
Intervention: Adolescent Haze Related Knowledge Awareness Assessment Scale (AHRKAAS)
Number of subjects: 1100
Study: 27192846

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia (SA)
Number of subjects: 67

Group type: COMPARATOR
Intervention: General anaesthesia (GA)
Number of subjects: 67
Study: 24141323

Group type: EXPERIMENTAL
Intervention: Deep Hypothermic Circulatory Arrest (DHCA)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Antegrade Cerebral Perfusion (ACP)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Both DHCA and ACP
Number of subjects: 37

Group type: COMPARATOR
Intervention: Postoperative arterial Pco2
Number of subjects: 37
Study: 22273813

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA
Number of subjects: 313

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 313
Study: 19626326

Group type: EXPERIMENTAL
Intervention: CT colonography with limited bowel preparation (180 ml diatrizoate meglumine, 80 ml barium, 30 mg bisacodyl)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Colonoscopy with full preparation (4 l of polyethylene glycol solution)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: CT colonography
Number of subjects: 173

Group type: COMPARATOR
Intervention: Colonoscopy
Number of subjects: 173
Study: 18685527

Group type: EXPERIMENTAL
Intervention: Cold drink (4 degrees C)
Number of subjects: 8
Study: 16579802

Group type: EXPERIMENTAL
Intervention: Fish oil (various doses)
Number of subjects: 3098

Group type: EXPERIMENTAL
Intervention: Flax oil (2.2 g of alpha-linolenic acid per day)
Number of subjects: 3098

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 3098
Study: 12568839

Group type: COMPARATOR
Intervention: 150 IU of Gonal-F
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 225 IU of Gonal-F
Number of subjects: 124
Study: 11198497

Group type: EXPERIMENTAL
Intervention: Febrile convulsions after 5 years of age (group 1)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Febrile convulsions before 5 years of age (group 2)
Number of subjects: 239
Study: 8833174

Group type: EXPERIMENTAL
Intervention: Soybean oil plus psyllium fiber (SO + PF)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Coconut oil plus psyllium fiber (CO + PF)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Soybean oil diet (SO)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Coconut oil diet (CO)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Psyllium fiber supplementation
Number of subjects: 10
Study: 1577155

Group type: EXPERIMENTAL
Intervention: i.v. salbutamol treatment (5 micrograms.kg‐1)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: inhaled salbutamol (0.15 mg.kg‐1 x 2)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: theophylline
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: terbutaline
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: salbutamol
Number of subjects: 140
Study: 6515508

Group type: EXPERIMENTAL
Intervention: Amoxycillin 1500 mg/d for 2 weeks and 1000 mg/d for 12 weeks thereafter
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Erythromycin stearate 1500 mg/d for 2 weeks and 1000 mg/d for 12 weeks thereafter
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 26
Study: 31744146

Group type: EXPERIMENTAL
Intervention: Metacognitive Training (MCT), 16 sessions
Number of subjects: 22

Group type: COMPARATOR
Intervention: Usual treatment (Control)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Metacognitive Training (MCT)
Number of subjects: 22
Study: 29889764

Group type: EXPERIMENTAL
Intervention: Elagolix 150 mg once daily
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: Elagolix 200 mg twice daily
Number of subjects: 569

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 569
Study: 27015283

Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg plus naproxen 1,000 mg/day
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo plus naproxen 1,000 mg/day
Number of subjects: 158
Study: 24692050

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 41
Study: 22584564

Group type: EXPERIMENTAL
Intervention: Intensive educational intervention (GI) with six weekly visits
Number of subjects: 47

Group type: COMPARATOR
Intervention: Conventional treatment (GC)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Intensive educational intervention (GI)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Changes in fiber intake
Number of subjects: 47
Study: 20385376

Group type: EXPERIMENTAL
Intervention: Active T-PEMF
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham T-PEMF
Number of subjects: 0
Study: 17999650

Group type: EXPERIMENTAL
Intervention: Acid infusion (HCl, 0.1 mol L(‐1))
Number of subjects: 43

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 43
Study: 15814401

Group type: EXPERIMENTAL
Intervention: Contraceptive advice during antenatal period
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Contraceptive advice during postpartum period
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Quality of information provided
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Short-term contraceptive methods information
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Midwives' training
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Midwives' confidence in knowledge
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Need for comprehensive discussion
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Regular training for midwives
Number of subjects: 64
Study: 14589461

Group type: EXPERIMENTAL
Intervention: Nonoperative treatment of neck pain
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cochrane review methodology
Number of subjects: 0
Study: 10511940

Group type: EXPERIMENTAL
Intervention: 1.1 mm TurboSonics tip
Number of subjects: 100

Group type: COMPARATOR
Intervention: 0.9 mm Aspiration Bypass System (ABS) tip
Number of subjects: 100
Study: 7853599

Group type: EXPERIMENTAL
Intervention: Directional atherectomy
Number of subjects: 73

Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 73
Study: 1660823

Group type: EXPERIMENTAL
Intervention: Azithromycin (1.5 g in five or six doses over 5 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Erythromycin (10 g in 40 doses over 10 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amoxycillin (15 g in 30 doses over 10 days)
Number of subjects: 0
Study: 7138752

Group type: EXPERIMENTAL
Intervention: Long-acting propranolol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Long-acting propranolol and bendrofluazide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combined formulation of long-acting propranolol/bendrofluazide (Inderex)
Number of subjects: 10

Group type: COMPARATOR
Intervention: All three preparations (LA propranolol, LA propranolol and bendrofluazide, combined formulation)
Number of subjects: 10

Group type: COMPARATOR
Intervention: LA propranolol alone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Bendrofluazide in two preparations
Number of subjects: 10
Study: 31422087

Group type: EXPERIMENTAL
Intervention: Ultrathin-strut cobalt-chromium Orsiro sirolimus-eluting stent (SES)
Number of subjects: 3514

Group type: COMPARATOR
Intervention: Durable-polymer thin-strut cobalt-chromium Resolute Integrity zotarolimus-eluting stent (ZES)
Number of subjects: 3514

Group type: EXPERIMENTAL
Intervention: Very-thin-strut platinum-chromium Synergy everolimus-eluting stent
Number of subjects: 3514
Study: 30132786

Group type: EXPERIMENTAL
Intervention: (-)-OSU6162 15 mg twice daily for 4 weeks, then 30 mg twice daily for 4 weeks, then 45 mg twice daily for 4 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: (-)-OSU6162
Number of subjects: 30
Study: 27725493

Group type: EXPERIMENTAL
Intervention: Prasugrel 20 mg
Number of subjects: 78

Group type: COMPARATOR
Intervention: Clopidogrel 300 mg
Number of subjects: 78
Study: 24381285

Group type: EXPERIMENTAL
Intervention: Neural representations formed at very early (180 ms) stages of encoding during recollection of images depicting faces and scenes.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recollection process occurring 500 ms after the onset of a cue that prompts recollection.
Number of subjects: 0
Study: 21822764

Group type: EXPERIMENTAL
Intervention: The Transporters DVD intervention for 3 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: The Transporters DVD intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (alternate DVD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thomas the Tank Engine condition
Number of subjects: 0
Study: 20374400

Group type: EXPERIMENTAL
Intervention: Computer-generated dosing group (CGD)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Standard management group (SM)
Number of subjects: 307
Study: 17666020

Group type: EXPERIMENTAL
Intervention: 100 mug vitamin K once daily
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 15087989

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 15

Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 15
Study: 11476013

Group type: EXPERIMENTAL
Intervention: silica‐based tartar control whitening dentifrice
Number of subjects: 187

Group type: COMPARATOR
Intervention: marketed regular dentifrice control
Number of subjects: 187
Study: 9736817

Group type: EXPERIMENTAL
Intervention: Successful kidney transplantation
Number of subjects: 125

Group type: COMPARATOR
Intervention: CAPD (Continuous Ambulatory Peritoneal Dialysis)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Hemodialysis
Number of subjects: 125
Study: 8002535

Group type: EXPERIMENTAL
Intervention: Benzodiazepine (1.5 mg lorazepam)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (gelatin)
Number of subjects: 7
Study: 2907669

Group type: EXPERIMENTAL
Intervention: 100 mg almitrine bismethylate
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 30300051

Group type: EXPERIMENTAL
Intervention: Feedback intervention group
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 28732324

Group type: EXPERIMENTAL
Intervention: FEC-Doc (taxane-anthracycline based chemotherapy)
Number of subjects: 170
Study: 26745107

Group type: EXPERIMENTAL
Intervention: Liquid-Based Cytology (LBC)
Number of subjects: 23030

Group type: COMPARATOR
Intervention: Conventional Cytology (CC)
Number of subjects: 23030
Study: 23427334

Group type: EXPERIMENTAL
Intervention: Polydextrose (PDX) at a dose of 20 g/d
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Soluble corn fiber (SCF) at a dose of 20 g/d
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Polydextrose (PDX)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Soluble corn fiber (SCF)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Polydextrose (PDX) and Soluble corn fiber (SCF)
Number of subjects: 36
Study: 22074749

Group type: EXPERIMENTAL
Intervention: OPPERA participants (185 with TMD)
Number of subjects: 3481

Group type: COMPARATOR
Intervention: Controls (1,633 without TMD)
Number of subjects: 3481
Study: 19486452

Group type: EXPERIMENTAL
Intervention: roxatidine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: rabeprazole
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: lansoprazole
Number of subjects: 120
Study: 15213026

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Safflower oil (SAF)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: DHA
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: EPA
Number of subjects: 33
Study: 10029956

Group type: EXPERIMENTAL
Intervention: Keyboard A (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Keyboard B (n = 10)
Number of subjects: 20
Study: 8838821

Group type: EXPERIMENTAL
Intervention: Rice-based oral rehydration solution (50 g/l)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Glucose-based WHO/UNICEF-recommended ORS
Number of subjects: 48
Study: 2248588

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment following removal of the foreign body
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (sterile saline)
Number of subjects: 0
Study: 6998553

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate-citrovorum factor rescue plus cyclophosphamide (MECY)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5-fluorouracil plus cyclophosphamide (FUCY)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corynebacterium parvum immunotherapy
Number of subjects: 0
Study: 30888329

Group type: EXPERIMENTAL
Intervention: MyLung mobile health app
Number of subjects: 30
Study: 28377297

Group type: EXPERIMENTAL
Intervention: 48h TTM at 33 ±1°C
Number of subjects: 105

Group type: COMPARATOR
Intervention: 24h TTM at 33 ±1°C
Number of subjects: 105
Study: 26644527

Group type: EXPERIMENTAL
Intervention: Symptom monitoring via tablet computers
Number of subjects: 766
Study: 24324046

Group type: EXPERIMENTAL
Intervention: Atenolol-based treatment
Number of subjects: 6549

Group type: EXPERIMENTAL
Intervention: Amlodipine-based treatment
Number of subjects: 6549

Group type: COMPARATOR
Intervention: Amlodipine-based treatment (NT-proBNP below median)
Number of subjects: 6549
Study: 21995319

Group type: EXPERIMENTAL
Intervention: Affirmation of afterlife belief
Number of subjects: 0

Group type: COMPARATOR
Intervention: Support of atheistic worldview
Number of subjects: 0
Study: 19180071

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 5145

Group type: COMPARATOR
Intervention: Diabetes Support and Education (DSE)
Number of subjects: 5145

Group type: EXPERIMENTAL
Intervention: Orlistat (as a toolbox option)
Number of subjects: 5145
Study: 17883910

Group type: EXPERIMENTAL
Intervention: Olopatadine 0.2%
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 15973255

Group type: EXPERIMENTAL
Intervention: Applied relaxation training with routine prenatal care
Number of subjects: 110

Group type: COMPARATOR
Intervention: Routine prenatal care only
Number of subjects: 110
Study: 11753054

Group type: EXPERIMENTAL
Intervention: Autologous transfusion combining ANH with ICS
Number of subjects: 145

Group type: COMPARATOR
Intervention: Standard transfusion practice (Allogeneic transfusion)
Number of subjects: 145